Kyeong-Han Park

Title: Kyeong-Han Park: Innovator in Melanoma Treatment and Skin Whitening

Introduction

Kyeong-Han Park is a notable inventor based in Chuncheon, South Korea. He has made significant contributions to the field of dermatology through his innovative research and patents. His work primarily focuses on developing treatments for melanoma and skin pigmentation issues.

Latest Patents

Kyeong-Han Park holds a patent for a "Microphthalmia-associated transcription factor-derived peptide and composition containing same." This patent provides small peptide fragments derived from the microphthalmia-associated transcription factor (MITF). The invention includes a method for preventing or treating melanoma using these peptide fragments as an active ingredient. Additionally, it offers a method for skin-whitening and inhibiting skin pigmentation, utilizing the peptide fragments as an active ingredient.

Career Highlights

Throughout his career, Kyeong-Han Park has worked with various organizations, including Supadelixir Inc. and Knu-Industry Cooperation Foundation. His experience in these companies has allowed him to advance his research and contribute to the development of innovative solutions in the field of skin health.

Collaborations

Kyeong-Han Park has collaborated with several professionals in his field, including Dong-Young Lim and Jang-Hee Hahn. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Kyeong-Han Park is a pioneering inventor whose work in melanoma treatment and skin whitening has the potential to make a significant impact in dermatology. His innovative approach and dedication to research continue to inspire advancements in skin health.